SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-20-007717
Filing Date
2020-04-01
Accepted
2020-04-01 17:21:41
Documents
6
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A nc10010435x1_pre14a.htm PRE 14A 1076789
2 logo_seelostherapeutics.jpg GRAPHIC 50919
3 nc10010435x1_pc01.jpg GRAPHIC 536924
4 nc10010435x1_pc02.jpg GRAPHIC 598294
5 nc10010435x1_pc03.jpg GRAPHIC 382828
6 sig_rajmehra.jpg GRAPHIC 10357
  Complete submission text file 0001140361-20-007717.txt   3231172
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-22245 | Film No.: 20766441
SIC: 2834 Pharmaceutical Preparations